468 related articles for article (PubMed ID: 27477280)
21. Acyl coenzyme a synthetase regulation: putative role in long-chain acyl coenzyme a partitioning.
Wang YL; Guo W; Zang Y; Yaney GC; Vallega G; Getty-Kaushik L; Pilch P; Kandror K; Corkey BE
Obes Res; 2004 Nov; 12(11):1781-8. PubMed ID: 15601973
[TBL] [Abstract][Full Text] [Related]
22. Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.
Bartolacci C; Andreani C; Vale G; Berto S; Melegari M; Crouch AC; Baluya DL; Kemble G; Hodges K; Starrett J; Politi K; Starnes SL; Lorenzini D; Raso MG; Solis Soto LM; Behrens C; Kadara H; Gao B; Wistuba II; Minna JD; McDonald JG; Scaglioni PP
Nat Commun; 2022 Jul; 13(1):4327. PubMed ID: 35882862
[TBL] [Abstract][Full Text] [Related]
23. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Fernández LP; Merino M; Colmenarejo G; Moreno-Rubio J; Sánchez-Martínez R; Quijada-Freire A; Gómez de Cedrón M; Reglero G; Casado E; Sereno M; Ramírez de Molina A
Mol Oncol; 2020 Dec; 14(12):3135-3152. PubMed ID: 33030783
[TBL] [Abstract][Full Text] [Related]
24. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
Wu M; Cao A; Dong B; Liu J
Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
[TBL] [Abstract][Full Text] [Related]
25. The acyl-CoA synthetase "bubblegum" (lipidosin): further characterization and role in neuronal fatty acid beta-oxidation.
Pei Z; Oey NA; Zuidervaart MM; Jia Z; Li Y; Steinberg SJ; Smith KD; Watkins PA
J Biol Chem; 2003 Nov; 278(47):47070-8. PubMed ID: 12975357
[TBL] [Abstract][Full Text] [Related]
26. [Research advances on the role of ACSL3 in the atherosclerosis].
Yang L; Yuan ZH
Sheng Li Xue Bao; 2023 Aug; 75(4):587-594. PubMed ID: 37583046
[TBL] [Abstract][Full Text] [Related]
27. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
28. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
Tian W; Wang D; Wang Z; Jiang K; Li Z; Tian Y; Kang X; Liu X; Li H
Gene; 2021 Jan; 764():145094. PubMed ID: 32860898
[TBL] [Abstract][Full Text] [Related]
29. Metabolic and tissue-specific regulation of acyl-CoA metabolism.
Ellis JM; Bowman CE; Wolfgang MJ
PLoS One; 2015; 10(3):e0116587. PubMed ID: 25760036
[TBL] [Abstract][Full Text] [Related]
30. Aspergillus nidulans contains six possible fatty acyl-CoA synthetases with FaaB being the major synthetase for fatty acid degradation.
Reiser K; Davis MA; Hynes MJ
Arch Microbiol; 2010 May; 192(5):373-82. PubMed ID: 20354844
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract][Full Text] [Related]
32. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
33. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects.
Ventura FV; Ruiter J; Ijlst L; de Almeida IT; Wanders RJ
Mol Genet Metab; 2005 Nov; 86(3):344-52. PubMed ID: 16176879
[TBL] [Abstract][Full Text] [Related]
34. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
[TBL] [Abstract][Full Text] [Related]
35. ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.
Migita T; Takayama KI; Urano T; Obinata D; Ikeda K; Soga T; Takahashi S; Inoue S
Cancer Sci; 2017 Oct; 108(10):2011-2021. PubMed ID: 28771887
[TBL] [Abstract][Full Text] [Related]
36. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
Terado T; Kim CJ; Ushio A; Minami K; Tambe Y; Kageyama S; Kawauchi A; Tsunoda T; Shirasawa S; Tanaka H; Inoue H
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894141
[TBL] [Abstract][Full Text] [Related]
37. Candida albicans fatty acyl-CoA synthetase, CaFaa4p, is involved in the uptake of exogenous long-chain fatty acids and cell activity in the biofilm.
Tejima K; Ishiai M; Murayama SO; Iwatani S; Kajiwara S
Curr Genet; 2018 Apr; 64(2):429-441. PubMed ID: 28942495
[TBL] [Abstract][Full Text] [Related]
38. Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation.
Black PN; DiRusso CC
Biochim Biophys Acta; 2007 Mar; 1771(3):286-98. PubMed ID: 16798075
[TBL] [Abstract][Full Text] [Related]
39. Ablation of insulin receptor substrates 1 and 2 suppresses
Xu H; Lee MS; Tsai PY; Adler AS; Curry NL; Challa S; Freinkman E; Hitchcock DS; Copps KD; White MF; Bronson RT; Marcotrigiano M; Wu Y; Clish CB; Kalaany NY
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4228-4233. PubMed ID: 29610318
[TBL] [Abstract][Full Text] [Related]
40. Targeting metabolic reprogramming in KRAS-driven cancers.
Kawada K; Toda K; Sakai Y
Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
